JP2013227228A - Muscle increasing agent - Google Patents

Muscle increasing agent Download PDF

Info

Publication number
JP2013227228A
JP2013227228A JP2012098413A JP2012098413A JP2013227228A JP 2013227228 A JP2013227228 A JP 2013227228A JP 2012098413 A JP2012098413 A JP 2012098413A JP 2012098413 A JP2012098413 A JP 2012098413A JP 2013227228 A JP2013227228 A JP 2013227228A
Authority
JP
Japan
Prior art keywords
muscle
increasing agent
exercise
fish
collagen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012098413A
Other languages
Japanese (ja)
Inventor
Naomi Asami
直美 麻見
Eriko Kawashima
恵利子 川島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JNC Corp
Original Assignee
JNC Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JNC Corp filed Critical JNC Corp
Priority to JP2012098413A priority Critical patent/JP2013227228A/en
Publication of JP2013227228A publication Critical patent/JP2013227228A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a muscle increasing agent effectively increasing muscles, having high safety, economical, and facilitating continuous use.SOLUTION: A muscle increasing agent contains a collagen peptide, as an active ingredient, obtained by hydrolysing collagen or gelatin derived from any one of a fish scale, fish bone, and fish skin, using a degrading enzyme derived from a bacillus.

Description

本発明は、筋肉増加剤に関する。   The present invention relates to a muscle increasing agent.

現代人の生活スタイルでは、運動機会の減少や食生活の欧米化により、肥満を引き起こす危険性が増している。肥満は、高血圧、高脂血症、心臓疾患、糖尿病などを引き起こす原因ともなるため、健康を維持する観点から、肥満を予防・改善することは極めて重要である。肥満の多くは、摂取エネルギーが消費エネルギーよりも高いことが原因となるため、消費エネルギーを増加させることが肥満の改善につながる。ここで、筋肉が増加すると基礎代謝に必要なエネルギーが増加するため、筋肉を増加させることにより、健康の維持・増進を図ることができる。
また、スポーツ選手のように筋肉の増加やその維持が必要となる場合にも、食事によって筋肉を増加させることができれば便利である。
In the lifestyles of modern people, there is an increased risk of causing obesity due to a decrease in exercise opportunities and westernization of dietary habits. Obesity can cause high blood pressure, hyperlipidemia, heart disease, diabetes, and the like, so it is extremely important to prevent and improve obesity from the viewpoint of maintaining health. Most obesity is caused by the fact that the energy consumed is higher than the energy consumed, so increasing the energy consumed leads to improvement in obesity. Here, since the energy required for basal metabolism increases when the muscle increases, the maintenance and promotion of health can be achieved by increasing the muscle.
Also, when muscles need to be increased or maintained, such as athletes, it is convenient if the muscles can be increased by eating.

従来、筋肉を増加させるためのタンパク質やペプチド、アミノ酸等を含有する筋肉増加剤や、これらを添加した加工食品、飲料、サプリメント、またステロイド剤のような筋肉増強剤が多数知られている(特許文献1〜4)。
しかし、従来のタンパク質やペプチド、アミノ酸等を含有する筋肉増加剤は、単に摂取するだけでは筋肉を増加させることはできず、運動と併用することにより、はじめて筋肉を増加させることが可能となるものが多かった。肥満を解消するために運動を行うことには苦痛が伴うため強い意志が必要となるし、筋肉の増加につながるような継続的な運動を行うのが難しい状況も現代人の生活スタイルでは多い。また、特許文献1に記載の筋肉増加剤は運動を必須としないが、牛肉由来の成分を含むため、感染症など安全性上の問題が存する。また、ステロイド剤を筋肉増強剤として用いると、肝機能障害、心機能障害、男性化、多毛症のような副作用を伴うことがあるため望ましくない。
このため、運動の有無に関係なく、簡便かつ安全に、筋肉を増加させることができる手段の開発が望まれている。
Conventionally, many muscle augmentation agents containing proteins, peptides, amino acids and the like for increasing muscle, and processed foods, beverages, supplements, and steroids added with these are known (patents). Literatures 1-4).
However, conventional muscle-enhancing agents containing proteins, peptides, amino acids, etc. cannot increase muscles simply by ingestion, and can only increase muscles when used together with exercise. There were many. Exercise to eliminate obesity is painful and requires a strong will, and there are many situations in modern lifestyles where it is difficult to do continuous exercise that leads to muscle growth. Moreover, although the muscle increasing agent of patent document 1 does not make exercise | movement essential, since it contains the component derived from beef, there exist safety problems, such as an infectious disease. In addition, use of a steroid as a muscle enhancer is not desirable because it may have side effects such as liver dysfunction, cardiac dysfunction, masculinization, and hirsutism.
For this reason, development of a means capable of increasing muscles simply and safely regardless of the presence or absence of exercise is desired.

ところで、近年、コラーゲン分解ペプチドに種々の効果が認められてきており、医薬品や機能性食品等に配合されている。例えば、ウシ・ブタ、魚等の皮膚・骨由来のコラーゲンの加水分解物を骨粗鬆症の治療等に適用したり(特許文献5〜7)、ブタやウシ等のコラーゲンの加水分解物を肥満防止剤の有効成分として含有させたり(特許文献8、9)、魚鱗類由来のコラーゲンを加水分解したペプチドを用いて血糖値の上昇を抑制したり(特許文献10)することが知られている。
また、本発明者らはこれまでに、魚鱗類由来のコラーゲンを継続して摂取した運動選手において、トレーニングによりつくり上げた体組成(体重、筋重量、脂肪量)が維持されることを報告している(非特許文献1)。
しかしながら、運動を併用せずともコラーゲンの摂取のみで筋肉を増加させることができることは、これまでに知られていなかった。
By the way, in recent years, various effects have been recognized on collagen-degrading peptides, and they are blended in pharmaceuticals and functional foods. For example, a collagen hydrolyzate derived from skin / bone such as bovine / pig / fish is applied to the treatment of osteoporosis or the like (Patent Documents 5 to 7), or a hydrolyzate of collagen such as pig or bovine is used as an anti-obesity agent. It is known to contain it as an active ingredient (Patent Documents 8 and 9) or to suppress an increase in blood glucose level using a peptide obtained by hydrolyzing fish scale-derived collagen (Patent Document 10).
In addition, the present inventors have previously reported that the body composition (body weight, muscle weight, fat mass) created by training is maintained in athletes who have continuously ingested fish scale-derived collagen. (Non-Patent Document 1).
However, it has not been known so far that muscles can be increased only by intake of collagen without using exercise.

特開2004−075637号公報JP 2004-075637 A 特開2004−292325号公報JP 2004-292325 A 特開号2004−256513公報JP 2004-256513 A 国際公開パンフレット2004/075905号International pamphlet 2004/075905 特開平11−12192号公報Japanese Patent Laid-Open No. 11-12192 特開2005−343852号公報JP 2005-343852 A 特開2008−231065号公報JP 2008-231065 A 特開2009−102233号公報JP 2009-102233 A 特開2002−20312号公報Japanese Patent Laid-Open No. 2002-20212 特開2002−326951号公報JP 2002-326951 A

FOOD Style 21, 2010年7月号(Vol.14, No.7)別刷, p.1-4FOOD Style 21, July 2010 (Vol.14, No.7) reprint, p.1-4

上記の通り、運動の有無に関係なく、簡便かつ安全に、筋肉を増加させることができる手段の開発が望まれている。また、筋肉を増加させるという体構成の変化は長い期間をかけて継続的に行うことが身体に負担をかけず好ましいため、有効性が高いことはもちろん、安全で経済的で継続しやすい態様の方法が求められる。
本発明はそのような状況に鑑み、摂取という簡便な手段のみで筋肉の増加に有効で、安全性が高く、経済的で、継続して用いやすい筋肉増加剤を提供することを課題とする。
As described above, it is desired to develop a means that can increase muscles simply and safely regardless of the presence or absence of exercise. In addition, it is preferable that the change in the body structure of increasing muscles is performed continuously over a long period of time because it does not place a burden on the body, so it is highly effective and of course an aspect that is safe, economical and easy to continue A method is required.
In view of such circumstances, an object of the present invention is to provide a muscle increasing agent that is effective for increasing muscles only by simple means of ingestion, is highly safe, economical, and easy to use continuously.

本願発明者らは、上記課題を解決するべく鋭意研究の末、コラーゲン又はゼラチンを加水分解して得られるコラーゲンペプチドを摂取することにより、筋肉増加効果が得られることを見出した。   The inventors of the present application have found that an effect of increasing muscles can be obtained by ingesting a collagen peptide obtained by hydrolyzing collagen or gelatin after intensive studies to solve the above problems.

すなわち、本発明は以下のとおりである。
(1)コラーゲン又はゼラチンを加水分解して得られるコラーゲンペプチドを有効成分として含有することを特徴とする筋肉増加剤。
(2)前記コラーゲン又はゼラチンが魚鱗、魚骨、及び魚皮のいずれかに由来する、(1)に記載の筋肉増加剤。
(3)前記魚鱗、魚骨、及び魚皮がスズキ目魚類由来である、(2)に記載の筋肉増加剤。
(4)前記加水分解が、バチルス(Bacillus)属由来の分解酵素を用いる加水分解である、(1)〜(3)のいずれかに記載の筋肉増加剤。
(5)前記コラーゲンペプチドの数平均分子量が500〜1500である、(1)〜(4)のいずれかに記載の筋肉増加剤。
(6)運動と併用して摂取されることを特徴とする、(1)〜(5)のいずれかに記載の筋肉増加剤。
(7)前記運動が中強度以上である、(6)に記載の筋肉増加剤。
That is, the present invention is as follows.
(1) A muscle increasing agent comprising a collagen peptide obtained by hydrolyzing collagen or gelatin as an active ingredient.
(2) The muscle increasing agent according to (1), wherein the collagen or gelatin is derived from any of fish scales, fish bones, and fish skins.
(3) The muscle increasing agent according to (2), wherein the fish scales, fish bones, and fish skin are derived from a perch fish.
(4) The muscle increasing agent according to any one of (1) to (3), wherein the hydrolysis is hydrolysis using a degrading enzyme derived from the genus Bacillus.
(5) The muscle increasing agent according to any one of (1) to (4), wherein the collagen peptide has a number average molecular weight of 500 to 1500.
(6) The muscle increasing agent according to any one of (1) to (5), which is taken together with exercise.
(7) The muscle increasing agent according to (6), wherein the exercise has a medium intensity or higher.

本発明の筋肉増加剤を摂取することにより、有効に筋肉を増加させることができる。具体的には、骨格筋が増加する。また、本発明の筋肉増加剤は、好ましくは魚鱗、魚骨及び魚皮から選択される一種以上に由来するコラーゲン又はゼラチンを原料とするため、安全性が高く経済的である。また、本発明の筋肉増加剤は入手しやすいため、継続しやすい筋肉増加対策を実現する。また、日常に取り入れやすい程度の運動負荷と併用すれば、より筋肉増加効果を高めることができる。   By taking the muscle increasing agent of the present invention, the muscle can be effectively increased. Specifically, skeletal muscle increases. Moreover, since the muscle increasing agent of the present invention is preferably made from collagen or gelatin derived from one or more selected from fish scales, fish bones and fish skins, it is highly safe and economical. Moreover, since the muscle increasing agent of this invention is easy to acquire, the countermeasure against the increase in muscle which is easy to continue is implement | achieved. In addition, when used in combination with an exercise load that is easy to incorporate in daily life, the effect of increasing muscles can be further enhanced.

体重補正した下肢筋湿重量値を表すグラフである。It is a graph showing the leg muscle wet weight value which corrected the body weight.

本発明の筋肉増加剤は、コラーゲンペプチドを有効成分として含有する。ここでコラーゲンペプチドとは、コラーゲン又はゼラチンを加水分解して得たペプチドを意味する。
コラーゲン又はゼラチンは、ウシ、ブタ、トリ、ヒツジ等の骨や皮や、魚類の鱗や骨、皮など、いずれから得たものであっても構わない。特に好ましくは、魚鱗、魚骨、及び魚皮から選択される一種以上から得たコラーゲン又はゼラチン由来のコラーゲンペプチドである。このようなペプチドは、ウシやブタ由来のコラーゲンペプチドに比して、家畜伝染病などの心配がなく安全性が高い点、さらに魚鱗、魚骨の場合は味や臭いを悪くする脂肪分の含有割合が非常に小さい点で、有用性が高い。
本発明の筋肉増加剤の原料となる魚鱗、魚骨、又は魚皮(以降、これらを魚鱗類と記す)を得る魚種としては、特に限定されず、イワシ、サンマ、ティラピア、マダイ、イトヨリダイ、フエフキダイ、ママカリ、サケ、ニシン、コイ、ナマズ、ハモ等を使用できるが、鱗中のコラーゲンの含有比率が高い点、及び鱗が比較的大きい点から、スズキ目魚種が好ましい。
The muscle increasing agent of the present invention contains a collagen peptide as an active ingredient. Here, the collagen peptide means a peptide obtained by hydrolyzing collagen or gelatin.
Collagen or gelatin may be obtained from any of bones and skins such as cows, pigs, birds and sheep, fish scales, bones and skins. Particularly preferred is a collagen peptide derived from collagen or gelatin derived from one or more selected from fish scales, fish bones, and fish skins. Compared with collagen peptides derived from cattle and pigs, such peptides are safer than livestock infectious diseases, and in the case of fish scales and fish bones, they contain fat that makes the taste and smell worse. It is highly useful in that the ratio is very small.
The fish species for obtaining fish scales, fish bones, or fish skins (hereinafter referred to as fish scales) as raw materials for the muscle increasing agent of the present invention are not particularly limited, and include sardines, saury, tilapia, red sea bream, red sea bream, Pufferfish, mamakari, salmon, herring, carp, catfish, sea cucumber, etc. can be used, but from the viewpoint of a high content ratio of collagen in scales and a relatively large scale, a perch species is preferred.

本発明におけるコラーゲンまたはゼラチンの加水分解物であるコラーゲンペプチドの製造条件は特に限定されるものではないが、例えば、酸脱灰後に熱水抽出して酵素加水分解する方法や、加圧による抽出後に酵素加水分解する方法などを挙げることができる。なかでも品質面で優れた酵素加水分解物が得られることから、本発明においては、酸脱灰後に熱水抽出して酵素加水分解する方法が好ましい。
酸脱灰後に熱水抽出して酵素分解する方法とは、具体的には、塩酸や酢酸等で脱灰、水洗浄した湿潤又は乾燥粗コラーゲンに対し重量比で5〜20倍量の40〜100℃の温水又は熱水を用い、1〜20時間かけてコラーゲンまたはゼラチンを抽出し、この抽出液にタンパク質分解酵素を加え、抽出されたコラーゲンまたはゼラチンを酵素加水分解する方法である。
The production conditions of the collagen peptide which is a hydrolyzate of collagen or gelatin in the present invention are not particularly limited. For example, a method of hydrolyzing and then hydrolyzing the enzyme after acid decalcification, or after extraction by pressurization Examples include enzymatic hydrolysis. In particular, since an enzyme hydrolyzate excellent in terms of quality can be obtained, in the present invention, a method of performing hydrothermal extraction after acid decalcification and enzymatic hydrolysis is preferable.
Specifically, the method of hydrolyzing after acid decalcification with hot water extraction is 40 to 20 to 20 times the weight ratio of wet or dry crude collagen deashed with hydrochloric acid or acetic acid and washed with water. In this method, collagen or gelatin is extracted for 1 to 20 hours using warm water or hot water at 100 ° C., and a proteolytic enzyme is added to the extract to enzymatically hydrolyze the extracted collagen or gelatin.

用いるタンパク質分解酵素としては、食品に使用できるものであり、高分解率で大量製造され比較的安価で入手可能で、アミノ酸の生成量が少ないものが好ましい。これらの諸条件を満足させる分解条件としては、コラーゲンがゼラチン化する40℃以上の温度と分解が容易なpH5.0〜8.0で使用できる中性酵素や、pH6.5〜12で使用できるアルカリ性酵素が好ましく、具体的にはバチルス(Bacillus)属由来の細菌性プロテアーゼが挙げられる。このような細菌性プロテアーゼとしては、中性酵素では例えばプロチンP(登録商標)(大和化成株式会社製)、オリエンターゼ(登録商標)90N(エイチビィアイ株式会社製)、プロテアーゼNアマノG(登録商標)(天野エンザイム株式会社製)等が挙げられ、アルカリ性酵素では例えばアルカラーゼ(登録商標)(ノボノルディスクバイオインダストリー株式会社製)、ビオプラーゼ(登録商標)SP−15FG(長瀬産業株式会社製)、プロレザー(登録商標)FG−F(天野製薬株式会社製)等が挙げられる。   As the proteolytic enzyme to be used, those that can be used in foods, are mass-produced with a high degradation rate, are available at a relatively low cost, and those that produce a small amount of amino acids are preferable. Degradation conditions that satisfy these conditions include neutral enzymes that can be used at a temperature of 40 ° C. or higher at which collagen is gelatinized and pH 5.0 to 8.0 that is easily decomposed, or pH 6.5 to 12. Alkaline enzymes are preferred, and specific examples include bacterial proteases derived from the genus Bacillus. Such bacterial proteases include, for example, protin P (registered trademark) (manufactured by Daiwa Kasei Co., Ltd.), orientase (registered trademark) 90N (manufactured by HIBI), and protease N Amano G (registered trademark). (Amano Enzyme Co., Ltd.) and the like. Examples of alkaline enzymes include Alcalase (registered trademark) (manufactured by Novo Nordisk Bioindustry Co., Ltd.), Biolase (registered trademark) SP-15FG (manufactured by Nagase Sangyo Co., Ltd.), Pro Leather (Registered trademark) FG-F (manufactured by Amano Pharmaceutical Co., Ltd.)

本発明でのコラーゲンペプチドは精製工程を経ることで、より品質が向上する。当該精製工程には活性炭処理が好適である。本発明において好適に行われる活性炭処理については、活性炭の種類やその使用量をはじめ特に限定されるものではない。本発明において好ましい活性炭処理方法としては、粗コラーゲンに対して1〜20重量%の活性炭を、酵素加水分解物を含有する溶液に添加し、30〜60℃の温度範囲で15〜360分撹拌する工程を、1〜5回繰り返し行う方法を挙げることができる。なお、精製工程に使用する活性炭は市販品を用いることができる。
精製に使用した活性炭は、活性炭処理後の溶液をろ過することにより取り除くことができる。ろ過の手段は特に限定されないが、例えば市販の珪藻土を粗コラーゲンに対して1〜50重量%の割合となるように添加し、フイルタープレス等でろ過することにより取り除くことができる。
The quality of the collagen peptide in the present invention is further improved through a purification process. Activated carbon treatment is suitable for the purification step. The activated carbon treatment suitably performed in the present invention is not particularly limited, including the type of activated carbon and the amount used. As a preferable activated carbon treatment method in the present invention, 1 to 20% by weight of activated carbon with respect to the crude collagen is added to a solution containing the enzyme hydrolyzate, and the mixture is stirred for 15 to 360 minutes in a temperature range of 30 to 60 ° C. The method of repeating a process 1-5 times can be mentioned. In addition, a commercial item can be used for the activated carbon used for a refinement | purification process.
Activated carbon used for purification can be removed by filtering the solution after the activated carbon treatment. The filtration means is not particularly limited, and for example, commercially available diatomaceous earth can be removed by adding 1 to 50% by weight with respect to the crude collagen and filtering with a filter press or the like.

精製されたコラーゲンペプチド水溶液は、濃縮工程を経ることにより液状のコラーゲンペプチドとして、または濃縮工程、乾燥粉末化工程を経ることにより、粉末状のコラーゲンペプチドとして用いることができる。好適な濃縮工程には薄膜蒸発機などの真空濃縮装置が挙げられ、乾燥粉末化工程にはスプレードライヤーなどが挙げられる。   The purified collagen peptide aqueous solution can be used as a liquid collagen peptide through a concentration step, or as a powdered collagen peptide through a concentration step and a dry powdering step. A suitable concentration process includes a vacuum concentration device such as a thin film evaporator, and a dry dryer process includes a spray dryer.

本発明の筋肉増加剤の有効成分であるコラーゲンペプチドの分子量は特に限定されるものではないが、ゲルクロマトグラフィー(GPC)法による数平均分子量で15000以下であることが好ましく、より好ましくは300〜5000の範囲であり、特により好ましくは500〜1500の範囲である。上記範囲であれば水に対する溶解性が良好で、かつ体内で早く吸収されることが予想されるため、効果の早い発現が望める。   The molecular weight of the collagen peptide which is an active ingredient of the muscle increasing agent of the present invention is not particularly limited, but is preferably 15000 or less, more preferably 300 to 300 in terms of number average molecular weight by gel chromatography (GPC) method. It is the range of 5000, More preferably, it is the range of 500-1500. If it is the said range, since the solubility with respect to water is favorable and it is anticipated that it will be absorbed rapidly in the body, it can expect the rapid expression of an effect.

本発明の筋肉増加剤は、コラーゲン又はゼラチンを加水分解して得られるコラーゲンペプチドを有効成分として含有し、筋肉増加剤中における該有効成分の含有量は筋肉増加効果を発揮できる量であれば特に制限はなく、摂取の頻度、摂取量、使用の目的によって適宜調整すればよい。少ない使用量で効果を発揮させる場合には、該含有量は多い方が好ましい。すなわち、筋肉増加剤全体の1〜100重量%含有することが好ましく、50〜100重量%含有することがより好ましく、80〜100重量%含有することがさらに好ましい。   The muscle increasing agent of the present invention contains a collagen peptide obtained by hydrolyzing collagen or gelatin as an active ingredient, and the content of the active ingredient in the muscle increasing agent is particularly an amount that can exert a muscle increasing effect. There is no limit, and it may be adjusted as appropriate according to the frequency of intake, the amount of intake, and the purpose of use. When the effect is exhibited with a small amount of use, it is preferable that the content is large. That is, it is preferably contained in an amount of 1 to 100% by weight, more preferably 50 to 100% by weight, and further preferably 80 to 100% by weight of the whole muscle increasing agent.

本発明の筋肉増加剤は、本発明の効果を損なわない限りにおいて、上記有効成分の他の成分を含有することができる。他の成分としては、例えば生理的に許容される賦形剤、結合剤、滑沢剤、崩壊剤、懸濁化剤、乳化剤、防腐剤、安定化剤、防腐剤、着色料、香料、その他種々の食品添加物等が挙げられる。
本発明の筋肉増加剤は、経口にて摂取される。その剤形としては、錠剤、コーティング錠剤、散剤、顆粒剤、カプセル剤、マイクロカプセル剤、シロップ剤、液剤等の形態を適用することができ、あるいは液体・固体を問わず飲食物に添加する形態でもよい。
The muscle increasing agent of the present invention can contain other components of the above active ingredients as long as the effects of the present invention are not impaired. Other components include, for example, physiologically acceptable excipients, binders, lubricants, disintegrants, suspending agents, emulsifiers, preservatives, stabilizers, preservatives, colorants, fragrances, and others. Various food additives and the like can be mentioned.
The muscle increasing agent of the present invention is taken orally. As the dosage form, forms such as tablets, coated tablets, powders, granules, capsules, microcapsules, syrups, and liquids can be applied, or forms added to food and drink regardless of liquid or solid But you can.

本発明の筋肉増加剤を飲食物に添加する場合、その形態としては、特に制限はないが、例えば飲料、栄養ドリンク、菓子、加工食品、油脂類、乳製品、レトルト食品、レンジ食品、冷凍食品、調味料、健康補助食品等の形態が挙げられる。添加される飲食物の形状・性状も特に制限されず、固体状、半固体状、ゲル状、液体状、粉末状等いずれでもよく、また、錠剤、カプセル剤、液剤、顆粒剤等いずれでもよい。   When the muscle increasing agent of the present invention is added to food and drink, the form thereof is not particularly limited, but for example, beverages, energy drinks, confectionery, processed foods, fats and oils, dairy products, retort foods, range foods, frozen foods , Forms such as seasonings and health supplements. The shape and properties of the added food and drink are not particularly limited, and may be any of solid, semi-solid, gel, liquid, powder, etc., and any of tablets, capsules, liquids, granules, etc. .

また、飲食物への添加を含め、本発明の筋肉増加剤を用いる場合は、各種機能の向上等を目的として、本剤の他の生理活性成分等をも配合したり組み合わせたりすることができる。
特に、筋肉増加効果の相加・相乗的な向上、筋肉増加効果の補助、吸収性の向上等を目的として、他の生理活性成分等と組み合わせることは好ましい。そのような目的における他の生理活性成分、その生理機能が明確であるものであれば特に制限は無いが、例えば、他の筋肉増加剤・筋肉増強剤や、筋肉増加用機能性飲食物等、例えば、ホエイタンパク、ホエイペプチド、カゼイン、大豆タンパク(プロテイン)、大豆ペプチド、小麦タンパク(プロテイン)、バリン、ロイシン、イソロイシン、アルギニン、シトルリン等のアミノ酸、リンゴポリフェノール、ウルソル酸、トマト抽出物(脂肪酸)、EMR(酵素処理ルチン)カテキン、クレアチン等が挙げられる。
In addition, when using the muscle increasing agent of the present invention, including addition to foods and drinks, other physiologically active ingredients of the agent can be blended or combined for the purpose of improving various functions. .
In particular, it is preferable to combine with other physiologically active ingredients and the like for the purpose of additive / synergistic improvement of the muscle increasing effect, assistance of the muscle increasing effect, improvement of absorbability, and the like. Other physiologically active ingredients for such purposes are not particularly limited as long as their physiological functions are clear, for example, other muscle-increasing agents, muscle-enhancing agents, functional foods for increasing muscles, etc. For example, whey protein, whey peptide, casein, soy protein (protein), soy peptide, wheat protein (protein), amino acids such as valine, leucine, isoleucine, arginine, citrulline, apple polyphenol, ursolic acid, tomato extract (fatty acid) , EMR (enzyme-treated rutin) catechin, creatine and the like.

また、その他の機能向上等を目的として組み合わせる他の生理活性成分としては、抗酸化成分、油性成分、栄養強化のための各種ビタミン類、ミネラル類、アミノ酸類等が挙げられる。
抗酸化成分としては、特に制限は無いが、例えば、トコフェロール類およびそれらの誘導体、トコトリエノール類およびそれらの誘導体、セサミン、エピセサミン、セサミノー
ル、セサモリン、セサモール等のリグナン類およびそれらの配糖体、β−カロチン等のカロテノイド類およびその誘導体、没食子酸やエラグ酸等のタンニン類およびそれらの誘導体、フラボン、カテキン、ケルセチン、ロイコアントシアニジン等のフラボノイド類、ユビキノンやビタミンK等のキノン類、オリザノール等のフェルラ酸誘導体、オリーブ抽出物等が挙げられる。栄養強化のための各種ビタミン類、ミネラル類、アミノ酸類等の種類については特に制限はないが、食品添加物公定書に定められるものが望ましい。
Other physiologically active ingredients combined for the purpose of improving other functions include antioxidant ingredients, oily ingredients, various vitamins, minerals, amino acids and the like for nutritional enhancement.
The antioxidant component is not particularly limited.For example, tocopherols and derivatives thereof, tocotrienols and derivatives thereof, lignans such as sesamin, episesamin, sesaminol, sesamorin, sesamol and glycosides thereof, β -Carotenoids such as carotene and its derivatives, tannins such as gallic acid and ellagic acid and their derivatives, flavonoids such as flavone, catechin, quercetin and leucoanthocyanidin, quinones such as ubiquinone and vitamin K, ferla such as oryzanol Examples include acid derivatives and olive extracts. There are no particular restrictions on the types of vitamins, minerals, amino acids, and the like for nutritional enhancement, but those specified in the Food Additives Official Document are desirable.

本発明の筋肉増加剤を添加する飲食物について、下記に具体例を列記するが、本発明はこれらに制限されるものではない。また、その形態等について特に制限はないが、例えば、おかき、煎餅、おこし、饅頭、飴等の和菓子、クッキー、ビスケット、クラッカー、パイ、カステラ、ドーナッツ、プリン、スポンジケーキ、ワッフル、バタークリーム、カスタードクリーム、シュークリーム、チョコレート、チョコレート菓子、キャラメル、キャンデー、チューインガム、ゼリー、ホットケーキ、パン、菓子パン等の各種洋菓子、ポテトチップ等のスナック菓子、アイスクリーム、アイスキャンデー、シャーベット等の氷菓、水、乳酸飲料、乳酸菌飲料、濃厚乳性飲料、果汁飲料、果肉飲料、機能性飲料、炭酸飲料等の清涼飲料水、緑茶、紅茶、コーヒー、ココア等の嗜好品およびこれらの飲料、牛乳、粉乳、発酵乳、加工乳、チーズ等の乳製品、豆乳、豆腐等の大豆加工食品、ジャム、果実のシロップ漬、フラワーペースト、ピーナツペースト、フルーツペースト等のペースト類、漬物類、うどんの麺、パスタ等の穀物製品類、ハム、ソーセージ、ベーコン、ドライソーセージ、ビーフジャーキー、ハンバーグ等の畜肉製品類、魚肉ハム、魚肉ソーセージ、かまぼこ、ちくわ、はんぺん等の魚貝類製品、魚、貝等の干物、鰹、鯖、鰺等の各種節、ウニ、イカ等の塩辛、スルメ、魚等のみりん干、鮭等の燻製品、のり、小魚、貝、山菜、椎茸、昆布等の佃煮、カレー、シチュー等のレトルト食品、みそ、醤油、ソース、ケチャップ、ブイヨン、焼肉のタレ、カレールー、シチューの素、スープの素、だしの素等の各種調味料、米飯類、パン、油脂やマーガリン、ショートニング、マヨネーズ、ドレッシング等の油脂加工品や、油脂を含有する各種レンジおよび冷凍食品等が挙げられる。   Although the specific example is listed below about the food / beverage to which the muscle increasing agent of this invention is added, this invention is not restrict | limited to these. There are no particular restrictions on the form of the cake, but examples include Japanese confectionery such as rice cake, rice cracker, rice cake, bun, rice cake, cookies, biscuits, crackers, pie, castella, donuts, pudding, sponge cake, waffles, butter cream, custard. Cream, cream puff, chocolate, chocolate confectionery, caramel, candy, chewing gum, jelly, hot cake, bread, confectionery such as bread, snacks such as potato chips, ice confectionery such as ice cream, popsicle, sherbet, water, lactic acid beverage, Lactic acid bacteria beverages, concentrated milk beverages, fruit juice beverages, fruit beverages, functional beverages, soft drinks such as carbonated beverages, taste products such as green tea, tea, coffee, cocoa and these beverages, milk, powdered milk, fermented milk, processed foods Dairy products such as milk and cheese, soy milk, tofu, etc. Processed foods, jams, fruit syrup pickles, pastes such as flower paste, peanut paste, fruit paste, pickles, udon noodles, pasta and other cereal products, ham, sausage, bacon, dry sausage, beef jerky, hamburg Livestock meat products such as fish ham, fish sausage, fish shell products such as kamaboko, chikuwa, hanpen, dried fish such as fish, shellfish, various sections such as salmon, salmon, salmon, salted sea urchin, squid, etc. Mirin, dried salmon, salmon and other salmon products, paste, small fish, shellfish, wild vegetables, shiitake mushrooms, kelp, etc., curry, stewed retort food, miso, soy sauce, sauce, ketchup, bouillon, grilled meat sauce, curry roux , Various ingredients such as stew, soup, dashi, etc., cooked rice, bread, oil and margarine, shortening, mayonnaise, dressing Of or oiled products, various ranges and frozen foods containing oils and fats can be cited.

本発明の筋肉増加剤の摂取量は各人の年齢、体重などに応じて異なるが、成人に対する一日の摂取量は、上記コラーゲンペプチドとして1〜20gが好ましく、5〜15gがより好ましい。また、1日のうち複数回に分けて摂取してもよく、摂取する人の日常生活に取り入れやすいようにすることができる。
摂取量を上記範囲とすることにより、筋肉を増加させる作用が促進される。
なお、本発明の筋肉増加剤を摂取する人(投与対象者)は、筋肉を増やしたい人であり、例えば運動選手や体力づくりをしたい人、肥満の解消や健康増進等の目的で消費エネルギーを増やしたい人が挙げられる。
The intake of the muscle increasing agent of the present invention varies depending on the age and weight of each person, but the daily intake for an adult is preferably 1 to 20 g, more preferably 5 to 15 g as the collagen peptide. Moreover, it may be taken in a plurality of times during a day, and can be easily taken into the daily life of the person who takes it.
By setting the intake amount within the above range, the action of increasing muscles is promoted.
In addition, the person (administration subject) who ingests the muscle increasing agent of the present invention is a person who wants to increase muscles. For example, an athlete, a person who wants to build physical strength, energy consumption for the purpose of eliminating obesity or improving health, etc. Some people want to increase.

本発明の筋肉増加剤は、好ましくは運動と併用して摂取される。運動を併用することにより、より筋肉増加効果が向上する。
ここで、運動とは身体活動を示し、計画的・意図的に実施する運動、労働、家事、通勤・通学、趣味等の日常の生活活動を含む。
負荷の程度としては3メッツ以上の中強度運動が好ましく、23エクササイズ(メッツ・時)/週以上の運動量が好ましい。なお、「メッツ」とは、厚生労働省の運動所要量・運動指針の策定検討会が「健康づくりのための運動指針2006(エクササイズガイド2006)」で示した、運動の強さを表す単位であり、座って安静にしている状態(1メッツ)を基準として、その何倍に相当するかで運動強度が表される。また、「エクササイズ(メッツ・時)」とは同様に、運動の量を表す単位であり、運動強度(メッツ)に運動時間をかけたものである。例えば、普通の歩行、ボーリング、バレーボール等が3メッツの運動に、速歩、水中運動、自転車こぎ等が4メッツの運動に該当し、3メッツの運動を毎日30分間/日行うと10.5エクササイズ/週となる。
運動を併用して本発明の筋肉増加剤を用いる場合、その摂取するタイミングとしては、
運動の前後いずれでもよく、特に制限されない。
運動頻度としては、毎日の実施が好ましいが、23エクササイズ(メッツ・時)/週以上となるように運動できればよい。
The muscle increasing agent of the present invention is preferably taken in combination with exercise. The combined use of exercise improves the effect of increasing muscles.
Here, exercise indicates physical activity, and includes daily life activities such as exercise, labor, housework, commuting / commuting, hobbies, etc. that are carried out systematically and intentionally.
As the degree of load, a medium intensity exercise of 3 mets or more is preferable, and an exercise amount of 23 exercises (mets · hour) / week or more is preferable. “Mets” is a unit that expresses the intensity of exercise as shown in the “Exercise Guidelines 2006 for Health Promotion (Exercise Guide 2006)” by the Ministry of Health, Labor and Welfare The exercise intensity is represented by how many times it is based on the sitting and resting state (1 Mets). Similarly, “exercise (mets / hour)” is a unit representing the amount of exercise, and is obtained by multiplying exercise intensity (mets) by exercise time. For example, normal walking, bowling, volleyball, etc. correspond to 3 Mets exercise, fast walking, underwater exercise, bicycle rowing, etc. correspond to 4 Mets exercise, and 10.5 exercise if 3 Mets exercise is performed for 30 minutes / day every day. / Week.
When using the muscle increasing agent of the present invention in combination with exercise,
It may be before or after exercise and is not particularly limited.
The exercise frequency is preferably daily, but it is sufficient that the exercise frequency is 23 exercise (mets · hour) / week or more.

本発明の筋肉増加剤又はこれを含有する飲食物は、筋肉増加のために用いられるものである旨の表示を付してもよい。筋肉増加のために用いられるものである旨の表示は、主に特定保健用食品として表示可能な表記であり、例えば「筋肉を増やして、健康な体づくりのために」「筋肉増加で基礎代謝をアップさせよう」「筋肉アップで脂肪の燃えやすい体に」等の表示が挙げられる。
また、本発明の筋肉増加剤又はこれを含有する飲食物は、運動と併用して摂取するものである旨の表示を付してもよい。運動と併用して摂取するものである旨の表示は、主に特定保健用食品として表示可能な表記であり、例えば「本剤/本飲食物を運動と一緒に摂取/飲食して、より筋肉の増加を」「摂取/飲食した後は運動を」「筋肉をより増やしたい方は、ウォーキング運動を」等の表示が挙げられる。
なお、これらの表示は、公知の方法で容器包装手段に付すことができ、これによって本発明の筋肉増加剤又はこれを含有する飲食物は筋肉増加のために用いられるものであること、又は運度と併用して摂取するものであることが明示されるので、通常の剤又は飲食物との区別が明確となる。
The muscle increasing agent of the present invention or food and drink containing the same may be labeled as being used for increasing muscle. The indication that it is used to increase muscles is a label that can be displayed mainly as a food for specified health use. For example, “Increase muscles to create a healthy body.” "Let's improve the body", "Muscle up to fat flammable body" and the like.
In addition, the muscle-increasing agent of the present invention or food and drink containing the same may be labeled as being taken together with exercise. The indication that it is ingested in combination with exercise is a notation that can be displayed mainly as a food for specified health use. For example, “Ingestion / drinking of this drug / food with exercise / "Increase the number of people", "Exercise after eating / drinking,""Walking exercise if you want to increase your muscles", and so on.
These indications can be attached to the container and packaging means by a known method, whereby the muscle-increasing agent of the present invention or foods and drinks containing it are used for increasing muscle, or Since it is clearly stated that it is to be taken in combination with the degree, the distinction from a normal agent or food and drink becomes clear.

本発明において筋肉増加作用とは、筋肉、特に骨格筋の量を増加させる作用を意味し、もとの筋肉の量を増やすこと、トレーニング等で増やした筋肉の量を減らさず維持することを含む。したがって、本発明の筋肉増加作用は、筋重量を測定することにより評価することができる。
本発明の筋肉増加剤を摂取することによって、運動の併用の有無にかかわらず筋肉を増加させることができることから、生活スタイルに合わせた無理のない筋肉増強に有効である。また、運動を併用することによってより筋肉増加効果を向上させることができるため、運動選手などの体づくりにも好適に利用できる。
In the present invention, the muscle increasing action means an action of increasing the amount of muscle, particularly skeletal muscle, and includes increasing the amount of the original muscle, maintaining the amount of muscle increased by training or the like without decreasing it. . Therefore, the muscle increasing effect of the present invention can be evaluated by measuring the muscle weight.
By ingesting the muscle increasing agent of the present invention, the muscle can be increased regardless of whether exercise is used or not, and this is effective for unreasonable muscle strengthening according to the lifestyle. Moreover, since the effect of increasing muscles can be further improved by using exercise together, it can be suitably used for body building of athletes and the like.

以下、実施例を挙げて本発明をさらに詳細に説明するが、本発明はこれらに限定されるものではない。   Hereinafter, although an example is given and the present invention is explained still in detail, the present invention is not limited to these.

<1>本発明の筋肉増加剤の製造
スズキ目の魚鱗を洗浄乾燥し、これを公知の方法により塩酸脱灰後、水洗(イオン交換水を使用)して粗コラーゲンを得た。すなわち、洗浄乾燥鱗100g(水分15重量%)に0.6モル塩酸1,500mLを加え、2時間攪拌した。100メッシュ網にてろ過(脱灰溶液pH1.5)、固形分を1Lのイオン交換水に入れて15分間攪拌し、この水洗/ろ過処理を3回繰り返した。105℃で3hr乾燥させた絶乾鱗の粗コラーゲン量は50重量%、N:17.4重量%、残カルシウム:0.12重量%、残リン酸分:0.37重量%であった。
該粗コラーゲンを20倍量(重量)のイオン交換水に懸濁し、これにBacillus subtilis由来のタンパク質分解酵素、天野エンザイム(株)製のプロテアーゼN「アマノ」G(
登録商標)を粗コラーゲンに対し1.0重量%の割合となるよう添加して50℃で3時間加水分解した。その後、活性炭「フタムラ化学(株)製 太閤S」(登録商標)を粗コラーゲンに対して0.4重量%加え、40℃において30分間攪拌処理して脱臭脱色した。その溶液を室温まで冷却後珪藻土ろ過し、濃縮、粉末化してコラーゲンペプチドを得た。
<1> Production of Muscle-Increasing Agent of the Present Invention Perch fish scales were washed and dried, and after decalcification with hydrochloric acid by a known method, washed with water (using ion-exchanged water) to obtain crude collagen. That is, 1,500 mL of 0.6 molar hydrochloric acid was added to 100 g of washed and dried scales (water content: 15% by weight) and stirred for 2 hours. Filtration through a 100-mesh net (decalcification solution pH 1.5), the solid content was put into 1 L of ion-exchanged water and stirred for 15 minutes, and this water washing / filtration treatment was repeated three times. The crude collagen content of the absolutely dry scale dried at 105 ° C. for 3 hours was 50% by weight, N: 17.4% by weight, residual calcium: 0.12% by weight, and residual phosphoric acid content: 0.37% by weight.
The crude collagen was suspended in 20 times (by weight) ion-exchanged water, and a protease N “Amano” G (produced by Amano Enzyme Co., Ltd.), a proteolytic enzyme derived from Bacillus subtilis.
(Registered Trademark) was added at a ratio of 1.0% by weight to the crude collagen and hydrolyzed at 50 ° C. for 3 hours. Thereafter, activated carbon “Tamura S manufactured by Futamura Chemical Co., Ltd.” (registered trademark) was added in an amount of 0.4% by weight to the crude collagen, and deodorized and decolored by stirring at 40 ° C. for 30 minutes. The solution was cooled to room temperature, filtered through diatomaceous earth, concentrated and powdered to obtain a collagen peptide.

上記で得たコラーゲンペプチドの数平均分子量を、写真用ゼラチン試験法合同審議会が定めるパギイ法20−2「平均分子量」に準じて、高速液体クロマトグラフィーを用いたゲル濾過法によって測定したところ、1010であった。
1)試料0.2gを100mLメスフラスコに取り、溶離液(0.1mol/Lリン酸二水素カリウム溶液と0.1mol/Lリン酸水素二ナトリウム溶液の等量混合液)を加え、1時間膨潤させた後、40℃で60分間加温して溶かした。室温まで冷却した後、溶離液を標線まで加えた。
2)得られた溶液を溶離液で正確に10倍希釈し、検液とした。
3)検液を用い、ゲル濾過法によってクロマトグラムを求めた。
カラム:Shodex Asahipak GS 620 7G を2本直列
溶離液の流速:1.0mL/min
カラムの温度:50℃
検出方法:測定波長230nmの吸光度
4)保存時間を横軸にとり、対応した230nmの吸光度値を縦軸にして、試料の分子分布曲線を作成し、数平均分子量を算出した。
When the number average molecular weight of the collagen peptide obtained above was measured by gel filtration using high performance liquid chromatography according to the Pagii Method 20-2 “Average Molecular Weight” defined by the Photographic Gelatin Test Method Joint Council, 1010.
1) Take 0.2 g of sample into a 100 mL volumetric flask and add eluent (equal mixture of 0.1 mol / L potassium dihydrogen phosphate solution and 0.1 mol / L disodium hydrogen phosphate solution) for 1 hour. After swelling, it was dissolved by heating at 40 ° C. for 60 minutes. After cooling to room temperature, the eluent was added to the marked line.
2) The obtained solution was diluted exactly 10 times with an eluent to prepare a test solution.
3) A chromatogram was obtained by gel filtration using the test solution.
Column: Two Shodex Asahipak GS 620 7G in series Eluent flow rate: 1.0 mL / min
Column temperature: 50 ° C
Detection method: Absorbance at a measurement wavelength of 230 nm 4) The storage time was taken on the horizontal axis, the corresponding absorbance value at 230 nm was taken on the vertical axis, a molecular distribution curve of the sample was created, and the number average molecular weight was calculated.

<2>筋肉増加作用試験
<2−1>試験方法
前記製造例のように製造した本発明の筋肉増加剤を用いて、筋肉増加作用試験を行った。
被験動物として5週齢のWistar系雄ラットを用いた。飼料のタンパク質源にはカゼインを用い、タンパク質含量を飼料重量に対し20重量%(標準食;Moderate :M)とした。また、飼料中のカゼイン100重量部中の30重量部を本発明の筋肉増加剤に置き換えた群(MC)を設けた。さらに各群を非運動群と運動群(Ex)とに分け、合計で表1に示す8群とした。
<2> Muscle-increasing action test <2-1> Test method A muscle-increasing action test was performed using the muscle-increasing agent of the present invention produced as in the above production example.
As test animals, 5-week-old male Wistar rats were used. Casein was used as the protein source of the feed, and the protein content was 20% by weight (standard diet; Moderate: M) based on the weight of the feed. Moreover, the group (MC) which replaced 30 weight part in 100 weight part of casein in feed with the muscle increasing agent of this invention was provided. Furthermore, each group was divided into a non-exercise group and an exercise group (Ex), and a total of 8 groups shown in Table 1 were obtained.

Figure 2013227228
Figure 2013227228

各群とも、予備飼育を1週間行った後、試験期間を11週間とした。
試験期間中は、23±1℃,湿度50±5%,12時間ごとの明暗サイクル(明期8:00a.m.〜8:00p.m.)の環境下でラットの飼育を行い、表2に示す組成の飼料及
び脱イオン蒸留水を自由摂取させた。
In each group, after the preliminary breeding for 1 week, the test period was 11 weeks.
During the test period, rats were raised in an environment of 23 ± 1 ° C., humidity 50 ± 5%, and light / dark cycle every 12 hours (light period 8:00 am to 8:00 pm). Feed and deionized distilled water having the composition shown in 2 were freely ingested.

Figure 2013227228
Figure 2013227228

また、試験期間中は運動負荷として、小動物用トレッドミル(KN−73、夏目製作所、東京)を用いた走行運動を、ラットに週6回の頻度で行わせた。運動適応期間を19日間設け、実験開始20日目から本走行を合計で55日間行った(25m/minを60min)。ランニングスピードは漸増的に上げ(25〜27m/min)、最終的に25m/minを15分、27m/minを45分の合計60分連続走行させた。なお、運動前後に準備運動(15m/minを5分)とクールダウン(15m/minを5分)を実施し、1日の総走行時間は70分とした。なお、本実施例の被験動物において25〜27m/minのランニングスピードは60〜70%VO2maxに相当し(Wheeler DL, Graves JE, Miller GL, Vander-Griend RE, Wronski TJ, Powers SK, Park HM. 1995. Effects
of running in the torisional strength, morphometry, and bone mass of the rat skeleton. Med Sci Sports Exerc 27: 520-529)、ヒトにおける中強度の運動負荷に相当する。
In addition, as an exercise load during the test period, a running exercise using a treadmill for small animals (KN-73, Natsume Seisakusho, Tokyo) was performed at a frequency of 6 times a week. The exercise adaptation period was set for 19 days, and the main run was carried out for a total of 55 days from the 20th day after the start of the experiment (25 m / min was 60 min). The running speed was gradually increased (25 to 27 m / min), and finally, 25 m / min was continuously run for 15 minutes and 27 m / min for 45 minutes for a total of 60 minutes. A preparatory exercise (15 m / min for 5 minutes) and a cool-down (15 m / min for 5 minutes) were performed before and after the exercise, and the total running time per day was 70 minutes. In the test animals of this example, a running speed of 25 to 27 m / min corresponds to 60 to 70% VO 2 max (Wheeler DL, Graves JE, Miller GL, Vander-Griend RE, Wronski TJ, Powers SK, Park HM. 1995. Effects
Med Sci Sports Exerc 27: 520-529), which corresponds to a medium-strength exercise load in humans.

体重及び飼料摂取量は2日ごとに計測した。飼育最終日に、12時間絶食させたラットをジエチルエーテル麻酔下で解剖して右側骨格筋(大腿四頭筋、腓腹筋、ヒラメ筋、足底筋)を採取して湿重量を測定した。
なお、測定値は統計処理を行い、全てmean±SEで表した。統計ソフトはSPSS(version 12.0J; Inc., Chicago, IL, USA)を使用し、各群の差は一元配置分散分析を用い検
討した。グループ間の多重比較はScheffe法を用い、危険率5%で検定した。
Body weight and feed intake were measured every 2 days. On the last day of breeding, rats fasted for 12 hours were dissected under diethyl ether anesthesia, and right skeletal muscles (quadriceps, gastrocnemius, soleus, plantar muscles) were collected and wet weight was measured.
The measured values were statistically processed and all expressed as mean ± SE. The statistical software was SPSS (version 12.0J; Inc., Chicago, IL, USA), and the difference between each group was examined using a one-way analysis of variance. Multiple comparisons between groups were performed using the Scheffe method with a risk rate of 5%.

<2−2>各評価項目及び結果
表3に最終体重、飼料摂取量、飼料効率を示す。
実験開始時の体重に各群間に差はなかった。最終体重、飼料摂取量では、本発明の筋肉増加剤の有無にかかわらず、運動群(MEx及びMCEx)が非運動群(M及びMC)よりもそれぞれ有意に低値を示した。また、飼料効率において運動群(MEx及びMCEx)は非運動群(M及びMC)と比較してそれぞれ有意に低値を示し、本発明の筋肉増加剤の摂取と運動負荷とを併用した群(MCEx)が最も低値だった。
<2-2> Each evaluation item and result Table 3 shows final body weight, feed intake, and feed efficiency.
There was no difference between groups in body weight at the start of the experiment. In the final body weight and feed intake, the exercise group (MEx and MCEx) showed significantly lower values than the non-exercise group (M and MC), respectively, regardless of the presence or absence of the muscle increasing agent of the present invention. In addition, in the feed efficiency, the exercise group (MEx and MCEx) showed a significantly lower value than the non-exercise group (M and MC), respectively, and the group in which intake of the muscle increasing agent of the present invention and exercise load were combined ( MCEx) was the lowest.

Figure 2013227228
Figure 2013227228

図1に右側骨格筋(大腿四頭筋、腓腹筋、ヒラメ筋、足底筋)の湿重量を、それぞれ体重補正した値として示す。
大腿四頭筋については、M群に比べてMC群は、有意差はなかったものの高値を示した。また本発明の筋肉増加剤と運動とを併用した群(MCEx)はM群よりも有意に高値を示した。腓腹筋、ヒラメ筋、足底筋についても、M群に比べてMC群は、有意差はなかったものの高値を示した。また、発明の筋肉増加剤と運動とを併用した群(MCEx)も、有意差はなかったものの高値または高値傾向を示した。
これらの結果から、本発明の筋肉増加剤の摂取により、特別な食餌や運動をせずとも、筋肉の増加を図ることができることが示された。さらに、本剤の摂取と併行して運動を行うことにより、さらに筋肉を増加させることができることが示された。
FIG. 1 shows wet weights of the right skeletal muscles (quadriceps, gastrocnemius, soleus, plantar muscles) as weight corrected values.
Regarding the quadriceps muscle, the MC group showed higher values than the M group although there was no significant difference. In addition, the group (MCEx) in which the muscle increasing agent of the present invention and exercise were used in combination showed a significantly higher value than the M group. Regarding the gastrocnemius, soleus and plantar muscles, the MC group showed higher values than the M group although there was no significant difference. In addition, the group (MCEx) in which the muscle increasing agent of the invention and exercise were used in combination showed a high value or a high value tendency although there was no significant difference.
From these results, it was shown that by taking the muscle increasing agent of the present invention, muscles can be increased without special diet or exercise. Furthermore, it was shown that muscles can be increased further by exercising in parallel with ingestion of this drug.

本発明により、筋肉の増加に有効で、安全性が高く、経済的で、継続して用いやすい筋肉増加剤が提供されるため、産業上非常に有用である。   According to the present invention, a muscle increasing agent that is effective in increasing muscle, is safe, economical, and easy to use continuously is provided.

Claims (7)

コラーゲン又はゼラチンを加水分解して得られるコラーゲンペプチドを有効成分として含有することを特徴とする筋肉増加剤。   A muscle increasing agent comprising a collagen peptide obtained by hydrolyzing collagen or gelatin as an active ingredient. 前記コラーゲン又はゼラチンが魚鱗、魚骨、及び魚皮のいずれかに由来する、請求項1に記載の筋肉増加剤。   The muscle increasing agent according to claim 1, wherein the collagen or gelatin is derived from any of fish scales, fish bones, and fish skins. 前記魚鱗、魚骨、及び魚皮がスズキ目魚類由来である、請求項2に記載の筋肉増加剤。   The muscle increasing agent according to claim 2, wherein the fish scales, fish bones, and fish skin are derived from a perch fish. 前記加水分解が、バチルス(Bacillus)属由来の分解酵素を用いる加水分解である、請求項1〜3のいずれか一項に記載の筋肉増加剤。   The muscle increasing agent according to any one of claims 1 to 3, wherein the hydrolysis is hydrolysis using a degrading enzyme derived from the genus Bacillus. 前記コラーゲンペプチドの数平均分子量が500〜1500である、請求項1〜4のいずれか一項に記載の筋肉増加剤。   The muscle increasing agent as described in any one of Claims 1-4 whose number average molecular weights of the said collagen peptide are 500-1500. 運動と併用して摂取されることを特徴とする、請求項1〜5のいずれか一項に記載の筋肉増加剤。   The muscle increasing agent according to any one of claims 1 to 5, which is taken together with exercise. 前記運動が中強度以上である、請求項6に記載の筋肉増加剤。   The muscle increasing agent of Claim 6 whose said exercise | movement is more than medium intensity | strength.
JP2012098413A 2012-04-24 2012-04-24 Muscle increasing agent Pending JP2013227228A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012098413A JP2013227228A (en) 2012-04-24 2012-04-24 Muscle increasing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012098413A JP2013227228A (en) 2012-04-24 2012-04-24 Muscle increasing agent

Publications (1)

Publication Number Publication Date
JP2013227228A true JP2013227228A (en) 2013-11-07

Family

ID=49675283

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012098413A Pending JP2013227228A (en) 2012-04-24 2012-04-24 Muscle increasing agent

Country Status (1)

Country Link
JP (1) JP2013227228A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014047147A (en) * 2012-08-30 2014-03-17 Q P Corp Net protein utilization ratio improver and method of manufacturing food/drink using the same, and method of improving serum net protein utilization ratio
WO2014092150A1 (en) * 2012-12-13 2014-06-19 新田ゼラチン株式会社 Myoblast differentiation accelerator
JP2018070644A (en) * 2014-05-20 2018-05-10 海南美合泰バイオテクノロジー カンパニー リミテッド Composition of natural vitamin c and collagen peptide and preparation method thereof
JP2019071792A (en) * 2016-07-11 2019-05-16 白澤 菊代 High protein curry roux
JP2019529365A (en) * 2016-08-30 2019-10-17 ゲリタ アクチェンゲゼルシャフト Use of collagen hydrolysates to improve endurance exercise capacity and stimulate lipid metabolism
WO2022231309A1 (en) * 2021-04-27 2022-11-03 경북대학교 산학협력단 Food composition and pharmaceutical composition for preventing or alleviating sarcopenia, containing low-molecular-weight collagen as active ingredient
WO2023022174A1 (en) * 2021-08-18 2023-02-23 株式会社 ニッピ Food composition for suppressing muscle fatigue and/or sudden muscle pain

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005281277A (en) * 2004-03-31 2005-10-13 Yaizu Suisankagaku Industry Co Ltd Hair-breeding and growing composition for oral intake and food and brink containing the composition
WO2010125910A1 (en) * 2009-04-28 2010-11-04 明治製菓株式会社 Collagen peptide composition having good blood transfer properties, and food and drink containing same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005281277A (en) * 2004-03-31 2005-10-13 Yaizu Suisankagaku Industry Co Ltd Hair-breeding and growing composition for oral intake and food and brink containing the composition
WO2010125910A1 (en) * 2009-04-28 2010-11-04 明治製菓株式会社 Collagen peptide composition having good blood transfer properties, and food and drink containing same

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
FOOD STYLE 21, vol. 14, no. 7, JPN6015046770, 2010, pages 62 - 65, ISSN: 0003199931 *
MACROMOL. BIOSCI., vol. 3, no. 10, JPN6015046774, 2003, pages 596 - 603, ISSN: 0003199933 *
ジャパンフードサイエンス, vol. 49, no. 7, JPN6015046772, 2010, pages 28 - 33, ISSN: 0003199932 *
日本栄養・食糧学会大会講演要旨集, vol. 66, JPN6016031709, 2012, pages 112, ISSN: 0003381657 *
治療, vol. 85, no. 11, JPN6016013775, 2003, pages 97 - 101, ISSN: 0003297758 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014047147A (en) * 2012-08-30 2014-03-17 Q P Corp Net protein utilization ratio improver and method of manufacturing food/drink using the same, and method of improving serum net protein utilization ratio
WO2014092150A1 (en) * 2012-12-13 2014-06-19 新田ゼラチン株式会社 Myoblast differentiation accelerator
US10632177B2 (en) 2012-12-13 2020-04-28 Nitta Gelatin Inc. Myoblast differentiation promoter
JP2018070644A (en) * 2014-05-20 2018-05-10 海南美合泰バイオテクノロジー カンパニー リミテッド Composition of natural vitamin c and collagen peptide and preparation method thereof
JP2019071792A (en) * 2016-07-11 2019-05-16 白澤 菊代 High protein curry roux
JP2019529365A (en) * 2016-08-30 2019-10-17 ゲリタ アクチェンゲゼルシャフト Use of collagen hydrolysates to improve endurance exercise capacity and stimulate lipid metabolism
WO2022231309A1 (en) * 2021-04-27 2022-11-03 경북대학교 산학협력단 Food composition and pharmaceutical composition for preventing or alleviating sarcopenia, containing low-molecular-weight collagen as active ingredient
WO2023022174A1 (en) * 2021-08-18 2023-02-23 株式会社 ニッピ Food composition for suppressing muscle fatigue and/or sudden muscle pain

Similar Documents

Publication Publication Date Title
JP2013227228A (en) Muscle increasing agent
KR101700016B1 (en) A muscle atrophy inhibitor
JP5594819B2 (en) Composition for improving lipid metabolism
JP2013124221A (en) Bone metabolism improver
JP6222663B2 (en) Muscle atrophy inhibitor
JP2010018522A (en) Adiponectin production enhancer
JPWO2018164254A1 (en) Composition for promoting BDNF increase in the body
JP5972235B2 (en) Blood triglyceride lowering agent
JP6942113B2 (en) Amino acid-containing composition
WO2015137387A1 (en) Muscle enhancing drug
JP6697245B2 (en) Endurance improver
JP2017523183A5 (en)
JP2013124222A (en) Visceral fat reducing agent
JP6252922B2 (en) Testosterone secretion promoter, anti-fatigue agent, and production method and use thereof
JP5712393B2 (en) Collagen absorption promoter and use thereof
JP2007238581A (en) Composition for ameliorating arthritis
JP6753618B2 (en) Composition for suppressing increase in triglyceride in blood
JP2020186264A (en) In-blood neutral fat increase inhibitory composition
JP6024942B2 (en) Testosterone secretion promoter, anti-fatigue agent, and production method and use thereof
JP2008044890A (en) Composition for breast enlargement and food and beverage for breast enlargement
JP2007269685A (en) Physiological function enhancing composition
JP2009256250A (en) Agent for maintaining or improving motility function
JP6173850B2 (en) Muscle bulking agent, muscle bulking agent when used together with exercise, and food and drink for muscle weight gain
JP6838752B2 (en) Blood flow improving composition
JP2008156292A (en) Peripheral bloodstream-improving agent and food composition having peripheral bloodstream-improving activity

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150205

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20151124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160121

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160412

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160707

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20160715

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20160819